人羊膜细胞外基质支架用于牙髓再生的体外与体内研究
本研究制备了多孔脱细胞人羊膜细胞外基质支架,比较15、22.5和30 mg/ml三种浓度的理化性能,并在体外评价人牙髓干细胞行为,在体内根段模型中评价牙髓样组织再生。30 mg/ml支架理化性能最佳且更支持细胞迁移,作为无细胞或有细胞支架均不干扰牙髓样组织形成与血管化。
要点
- 30 mg/ml人羊膜细胞外基质支架理化性能最佳并更支持人牙髓干细胞迁移。
- 该支架作为无细胞或有细胞支架均不干扰根管内牙髓样组织形成与血管化。
- 作者认为结果提示人羊膜细胞外基质膜在再生牙髓病学中有进一步研究潜力。
核心结论
- 30 mg/ml人羊膜细胞外基质支架理化性能最佳并更支持人牙髓干细胞迁移。
- 该支架作为无细胞或有细胞支架均不干扰根管内牙髓样组织形成与血管化。
- 作者认为结果提示人羊膜细胞外基质膜在再生牙髓病学中有进一步研究潜力。
研究设计与样本
- 体外与体内实验研究,制备15、22.5和30 mg/ml三种浓度脱细胞人羊膜细胞外基质支架。
- 体外用人牙髓干细胞评价活性、增殖、黏附和迁移,体内用根段模型评价牙髓再生。
- 非参数数据用Kruskal-Wallis检验后Dunn事后检验,定量数据用单因素方差分析。
主要发现
- 脱细胞处理得到确认(p < .05)。
- 所有支架孔隙率均超过95%,孔径随细胞外基质浓度升高而减小(p < .01)。
- 磷酸盐缓冲液吸收各组间无显著差异,30 mg/ml细胞外基质支架降解率最高(p < .01)。
- 人牙髓干细胞黏附于支架,各组增殖率随时间增加(p < .001);30 mg/ml细胞外基质支架细胞迁移更高(p < .05)。
- 30 mg/ml细胞外基质支架体内研究显示轻至中度炎症反应;根段中无细胞与有细胞支架均被新形成的牙髓样组织替代,组间无显著差异,免疫组化显示高血管化与胶原含量且组间无显著差异。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: In order to obtain a 3-dimentional scaffold with predictable clinical results for pulp regeneration, this study aims to fabricate and characterize a porous decellularized human amniotic membrane (HAM) extracellular matrix (ECM) scaffold, and evaluate its potential to promote pulp regeneration in vitro and in vivo. METHODOLOGY: The HAM was decellularized, and its histology and DNA content were analysed to confirm decellularization. The scaffolds were synthesized with 15, 22.5 and 30 mg/ml concentrations. The porosity, pore size, phosphate-buffered saline (PBS) absorption and degradation rate of the scaffolds were assessed. In vitro experiments were performed on human dental pulp stem cells (hDPSCs) to assess their viability, proliferation, adhesion and migration on the scaffolds. The optimal group was selected for in vivo immunogenicity assessment and was also used as the cell-free or cell-loaded scaffold in root segment models to evaluate pulp regeneration. All nonparametric data were analysed with the Kruskal-Wallis test followed by Dunn's post hoc test, whilst quantitative data were analysed with one-way anova. RESULTS: Decellularization of HAM was confirmed (p < .05). The porosity of all scaffolds was more than 95%, and the pore size decreased with an increase in ECM concentration (p < .01). PBS absorption was not significantly different amongst the groups, whilst 30 mg/ml ECM scaffold had the highest degradation rate (p < .01). The hDPSCs adhered to the scaffold, whilst their proliferation rate increased over time in all groups (p < .001). Cell migration was higher in 30 mg/ml ECM scaffold (p < .05). In vivo investigation with 30 mg/ml ECM scaffold revealed mild to moderate inflammatory response. In root segments, both cell-free and cell-loaded 30 mg/ml scaffolds were replaced with newly formed, pulp-like tissue with no significant difference between groups. Immunohistochemical assessments revealed high revascularization and collagen content with no significant difference amongst the groups. CONCLUSION: The 30 mg/ml HAM ECM scaffold had optimal physical properties and better supported hDPSC migration. The HAM ECM scaffold did not interfere with formation of pulp-like tissue and revascularization within the root canal when employed as both cell-free and cell-loaded scaffold. These results highlight the potential of HAM ECM membrane for further investigations in regenerative endodontics.
引用
- Bakhtiar H, Ashoori A, Rajabi S, et al. Human amniotic membrane extracellular matrix scaffold for dental pulp regeneration in vitro and in vivo. Int Endod J. 2021. PMID: 34923640. doi:10.1111/iej.13675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。